| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2016 | 2019 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2016 | 2019 | |||||||||
|
SLC2A1 antisense RNA 1 | 1.000 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||||
|
PABPC4 antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | |||||||||
|
family with sequence similarity 86, member A pseudogene | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2017 | |||||||||
|
hemoglobin subunit delta | 0.659 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1122 | 0.821 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1184 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2019 | |||||||||
|
DPY19L1 pseudogene 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
inhibitor of carbonic anhydrase pseudogene | 0.890 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
TPT1 antisense RNA 1 | 0.821 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 582 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
centrosomal protein 164 pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
chondroitin sulfate proteoglycan 4 pseudogene 13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
PRMT5 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
L3MBTL2 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1 | 0.792 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2615 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
RNA, 5S ribosomal pseudogene 244 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||||
|
ANTXR like pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
VPS33B divergent transcript |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
SPRY4 antisense RNA 1 | 0.890 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1471 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |